« Back

John D. Diekman, Ph.D.

Independent Director

John D. Diekman, Ph.D., joined our Board in 2017 and serves as Lead Independent Director and as a member of the Audit, Compensation, and Nominating and Corporate Governance Committees.

Dr. Diekman is an experienced executive who brings to our Board extensive business, management, policy, and capital markets experience as well as deep expertise in the life sciences and venture capital industries, including in the area of oncology.

Dr. Diekman is founder and managing partner of 5AM Ventures, where he has served since 2002. In addition to serving on our Board, he has served on other public company boards, including as Chairman of IDEAYA Biosciences, Inc. (Nasdaq) from 2015 to 2020. He also serves as Chairman of The Scripps Research Institute and has previously served as a member of the Advisory Board of the Schaeffer Center for Health Policy and Economics at the University of Southern California, as Charter Trustee of Princeton University, and as Trustee of the California Institute of Technology.

He received a Ph.D. in Chemistry from Stanford University and an A.B. in Organic Chemistry from Princeton University.

Independent Director